HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingyong Hou Selected Research

alcohol sulfotransferase

1/2020Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingyong Hou Research Topics

Disease

49Neoplasms (Cancer)
06/2022 - 02/2002
10Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2021 - 01/2013
9Esophageal Squamous Cell Carcinoma
12/2021 - 08/2012
8Stomach Neoplasms (Stomach Cancer)
11/2021 - 08/2012
5Lung Neoplasms (Lung Cancer)
01/2021 - 08/2014
5Neoplasm Metastasis (Metastasis)
10/2017 - 04/2014
4Sarcoma (Soft Tissue Sarcoma)
04/2021 - 10/2016
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 05/2014
4Colorectal Neoplasms (Colorectal Cancer)
05/2020 - 10/2014
3Carcinogenesis
12/2020 - 04/2003
3Breast Neoplasms (Breast Cancer)
01/2018 - 09/2002
3Carcinoma (Carcinomatosis)
08/2014 - 08/2012
2Residual Neoplasm
12/2021 - 02/2021
2Renal Cell Carcinoma (Grawitz Tumor)
11/2021 - 01/2021
2Lymphoma (Lymphomas)
01/2021 - 12/2014
2Paraganglioma (Paragangliomas)
10/2020 - 01/2018
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018 - 01/2015
2Leiomyosarcoma
01/2015 - 04/2002
2Synovial Sarcoma (Synovioma)
04/2003 - 10/2002
2Leiomyoma (Uterine Fibroids)
04/2002 - 02/2002
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2022
1Non-Muscle Invasive Bladder Neoplasms
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021
1Alveolar Soft Part Sarcoma
01/2021
1Esophageal Neoplasms (Esophageal Cancer)
12/2020
1Adenocarcinoma
12/2020
1Hypoxia (Hypoxemia)
10/2020
1Non-alcoholic Fatty Liver Disease
01/2020
1Adenosquamous Carcinoma
01/2020
1Fatty Liver
01/2020
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2019
1Malignant mesenchymal tumor
02/2019
1Lymphatic Metastasis
01/2019
1Burkitt Lymphoma (Burkitt's Lymphoma)
12/2018
1alpha-Thalassemia
01/2018
1Hypertriglyceridemia
01/2018

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
04/2022 - 06/2014
9Imatinib Mesylate (Gleevec)FDA Link
01/2020 - 07/2013
7Proteins (Proteins, Gene)FDA Link
09/2021 - 09/2002
5Biological ProductsIBA
01/2020 - 02/2002
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2002
4Messenger RNA (mRNA)IBA
11/2021 - 09/2002
4ParaffinIBA
01/2020 - 01/2013
4MicroRNAs (MicroRNA)IBA
01/2018 - 06/2014
3Tyrosine Kinase InhibitorsIBA
11/2021 - 05/2014
3Trastuzumab (Herceptin)FDA Link
11/2019 - 08/2012
3AntibodiesIBA
05/2014 - 02/2002
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
2Phosphotransferases (Kinase)IBA
01/2022 - 04/2021
2CrizotinibIBA
04/2021 - 02/2019
2B7-H1 AntigenIBA
01/2021 - 12/2020
2ErbB Receptors (EGF Receptor)IBA
01/2021 - 05/2014
2Rituximab (Mabthera)FDA Link
01/2021 - 12/2018
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2020
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2019 - 08/2016
2Pharmaceutical PreparationsIBA
08/2017 - 08/2014
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2016 - 01/2015
2DesminIBA
04/2002 - 02/2002
1Monoclonal AntibodiesIBA
04/2022
1McAb NJ001IBA
04/2022
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
01/2022
1Antigen-Antibody Complex (Immune Complex)IBA
01/2022
1OsteopontinIBA
11/2021
1LB100IBA
09/2021
1130-nm albumin-bound paclitaxelIBA
09/2021
1Paclitaxel (Taxol)FDA LinkGeneric
09/2021
1tyrosine receptor (receptor, tyrosine)IBA
04/2021
1Complement System Proteins (Complement)IBA
01/2021
1CurcuminIBA
01/2021
1chlorotriphenylsilane (CTPS)IBA
01/2021
1Cell-Free Nucleic AcidsIBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1human ERBB2 proteinIBA
12/2020
1Epinephrine (Adrenaline)FDA LinkGeneric
10/2020
1CatecholaminesIBA
10/2020
1Urethane (Ethyl Carbamate)IBA
06/2020
1Formaldehyde (Formol)FDA Link
01/2020
1Liver X ReceptorsIBA
01/2020
1Triglycerides (Triacylglycerol)IBA
01/2020
1immune RNA (I-RNA)IBA
01/2020
1alcohol sulfotransferaseIBA
01/2020
1Glutamic Acid (Glutamate)FDA Link
01/2020
1T0901317IBA
01/2020
1DNA Glycosylases (DNA Glycosylase)IBA
12/2019
1CateninsIBA
12/2019
1Anaplastic Lymphoma KinaseIBA
02/2019
1Tumor Biomarkers (Tumor Markers)IBA
02/2019
1midostaurinIBA
12/2018
1Complement C3b (C3bi)IBA
01/2018
1WW Domain-Containing OxidoreductaseIBA
01/2018

Therapy/Procedure

16Therapeutics
06/2022 - 07/2013
5Neoadjuvant Therapy
12/2021 - 06/2017
3Drug Therapy (Chemotherapy)
09/2021 - 08/2014
3Aftercare (After-Treatment)
04/2021 - 12/2014
2Molecular Targeted Therapy
04/2021 - 08/2014
2Esophagectomy
01/2021 - 06/2017
2Immunotherapy
01/2021 - 01/2020
1Hepatectomy
01/2020
1Precision Medicine
02/2019